Christopher Watt
Nessuna posizione attualmente
Storia della carriera di Christopher Watt
Precedenti posizioni note di Christopher Watt
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| TETRAPHASE PHARMACEUTICALS, INC. | Direttore Finanziario/CFO | 01/07/2015 | 28/07/2020 |
| BIOGEN INC. | Corporate Officer/Principal | 01/01/2006 | 01/07/2015 |
Formazione di Christopher Watt
| Colby College | Undergraduate Degree |
| University of Michigan | Masters Business Admin |
Statistiche
Distribuzione geografica
| Stati Uniti | 5 |
Posizioni
| Director of Finance/CFO | 1 |
| Undergraduate Degree | 1 |
| Masters Business Admin | 1 |
Settori
| Health Technology | 3 |
| Consumer Services | 3 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| BIOGEN INC. | Health Technology |
| Aziende private | 1 |
|---|---|
Tetraphase Pharmaceuticals, Inc.
 Tetraphase Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Tetraphase Pharmaceuticals, Inc. is engaged in the development and production of novel tetracyclines for serious and life-threatening bacterial infections. It also develops eravacycline, a synthetic fluorocycline, as an intravenous and oral antibiotic for use as a first-line empiric monotherapy for the treatment of resistant and multi-drug-resistant infections. The company was founded on July 7, 2006 and is headquartered in Waltham, MA. | Health Technology |
- Borsa valori
- Insiders
- Christopher Watt
- Esperienza
